Certainly anything they can do to allow information to be verified, especially on Nas….investors imaginations are not as productive here as on the OTC.
As for cashflow…don’t know how far the $6-7 million will get them in this. Drug testing is expensive.
How much were they originally targeting for a raise?
News 
Market Data 
Discover 
AI
